Navigation Links
News brief: Adverse symptom reporting by patients vs. clinicians

Clinician's and patient's adverse symptom reports may be discrepant from each other, but provide complementary, clinically meaningful information, according to a new study published online November 17 in the Journal of the National Cancer Institute.

In cancer clinical trials, it is currently standard for clinicians rather than patients to report adverse symptoms such as nausea or fatigue. Patient self-reporting is an alternative approach that is not well studied and is of unknown scientific value.

Ethan Basch, M.D., M.Sc., of the Health Outcomes Group, Memorial Sloan-Kettering Cancer Center in New York, and colleagues gathered data from more than 160 lung cancer patients and their clinicians for six common symptoms reported via the standard adverse event reporting lexicon in oncology trials, the National Cancer institute's Common Terminology Criteria for Adverse Events (CTCAE).

Patients generally reported adverse symptoms earlier, more frequently, and with greater severity than their clinicians. Patient-reported symptoms were more highly associated with day-to-day health status, whereas clinician reports were more predictive of death and hospitalization.

"Patient and clinician perspectives of adverse symptoms appear to be complementary, together providing a more complete picture of the toxic impact of treatments compared with either perspective alone," the authors write. "Clinicians bring professional training and experience to their evaluations, whereas patients are in a better position to communicate their own subjective experiences."

In an accompanying editorial, Carolyn Gotay, Ph.D., of the School of Population and Public Health, University of British Columbia, in Vancouver, commends the study's collection of comparable data from both groups and impressive response rates, but points out some of the potential biases in reports that arise from the patient's perspective: motivation, interpretation, expectations, and personality.

Symptom ratings are therefore affected not only by the disease and treatment but also by other characteristics the patients bring to the situation, according to the editorialist. She suggests how this information may be used to define possible adverse events on label warnings.


Contact: Steve Graff
Journal of the National Cancer Institute

Related medicine news :

1. In brief: New prognostic indicator for patients with IPF
2. JNCI news brief: Improving the biomarker pipeline for early cancer detection
3. JNCI news brief: Hepatitis B virus mutations may predict risk of liver cancer
4. JNCI news brief: Breast cancer hormone receptor status and risk of a second primary tumor
5. JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
6. JNCI news brief: High serum insulin levels and risk of prostate cancer
7. JNCI news brief: Surgeon training found effective in breast cancer sentinel lymph node trial
8. JNCI news brief: Melanosome dynamics and sensitivity of melanoma cells to chemotherapy
9. JNCI news brief: STD confirmed to be associated with increased risk of prostate cancer
10. News brief: Effects of aspirin and folic acid on inflammation markers for colorectal adenomas
11. Adverse housing conditions contribute to diabetes risk
Post Your Comments:
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... 2017  NDS received FDA 510(k) clearance in May 2017 for ... stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ... solution to support the improvement of patient outcomes, procedural efficiency, and ... ... ...
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
Breaking Medicine Technology: